Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Variation in the Treatment of Multiple Myeloma in the Real World

Joshua Richter, MD, Leena Chhun, B.S., Cheng Zheng, B.S., Jayne Piboonvaranggoon, B.S., Elora Mallick, B.S., Jennifer Wren, B.S., Grace Nam, M.S., Ricardo Lopez Barquilla, PhD, Alexandra Dardac, B.S., Sibel Blau, MD, Francis M. Senecal, MD, Swathi Namburi, MD, Andrew J. Cowan, MD, William I Bensinger, MD, Shaji K. Kumar, MD, Paul G. Richardson, MD, Kenneth Anderson, MD, C. Anthony Blau, MD

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-138705

Published: 2020

Journal Articles

A Precision Medicine Approach Incorporating Both Molecular and In Vitro Functional Data to Treat Patients with Relapsed/Refractory Acute Myeloid Leukemia

Blood (2016) 128 (22): 4043.

https://doi.org/10.1182/blood.V128.22.4043.4043

Published: 2016

Journal Articles

Toward Individualized Therapy: Correlation of Mutation Analysis with in Vitro high Throughput Drug Sensitivity Testing in New Diagnosis and Relapsed Acute Myeloid Leukemia

Pamela S. Becker, MD PhD, Michael W. Schmitt, MD PhD, Zhiyi Xie, PhD, Andrew R Carson, PhD, Bradley Patay, MD, Seyed Sina Khankhajeh, Qi Wei, Ling-Hong Hung, Timothy Martins, PhD, Elihu H. Estey, MD, C. Anthony Blau, MD, Vivian G. Oehler, MD, Ka Yee Yeung, PhD

Blood (2015) 126 (23): 3851.

https://doi.org/10.1182/blood.V126.23.3851.3851

Published: 2015

Journal Articles

Feasibility Trial of Individualized Therapy for Relapsed or Refractory Acute Myeloid Leukemia Based on a High Throughput in Vitro Drug Sensitivity Assay

Pamela S. Becker, MD PhD, Vivian Oehler, MD, Elihu H. Estey, MD, Timothy Martins, PhD, Andrea Perdue, PA-C, Jodie David, RN, Sylvia Chien, Paul C. Hendrie, MD PhD, Fabiana Ostronoff, MD, C. Anthony Blau, MD

Blood (2014) 124 (21): 3748.

https://doi.org/10.1182/blood.V124.21.3748.3748

Published: 2014

Journal Articles

Big Data Approach to Identify Molecular Basis for Drug Sensitivity Phenotypes in Acute Myeloid Leukemia

Su-In Lee, PhD, Benjamin Logsdon, PhD, Akanksha Saxena, BS, Vivian Oehler, MD, Chris P. Miller, PhD, C. Anthony Blau, MD, Pamela S. Becker, MD PhD

Blood (2014) 124 (21): 265.

https://doi.org/10.1182/blood.V124.21.265.265

Published: 2014

Journal Articles

Characterization Of FLT3 /ITD Resistant Cells and Identification Of Novel Therapeutic Targets Utilizing High Throughput Drug Screening

Katherine Tarlock, MD, C. Anthony Blau, MD, Timothy Martins, PhD, Soheil Meshinchi, MD, PhD

Blood (2013) 122 (21): 2522.

https://doi.org/10.1182/blood.V122.21.2522.2522

Published: 2013

Journal Articles

Proof-Of-Concept Study For Precision Medicine With Chromosome Genomic Array Testing (CGAT) For Drug Sensitivity Screening In Acute Myeloid Leukemia

Min Fang, MD, PhD, Scott McElhone, Xin Zhao, MD, Barry E. Storer, PhD, Su-In Lee, Ph.D., C. Anthony Blau, MD, Vivian G. Oehler, MD, Elihu H. Estey, MD, Frederick R. Appelbaum, MD, Pamela S Becker, MD, PhD

Blood (2013) 122 (21): 2578.

https://doi.org/10.1182/blood.V122.21.2578.2578

Published: 2013

Journal Articles

Personalized Approach To Treatment of Acute Myeloid Leukemia Using a High-Throughput Chemosensitivity Assay

Ka Yee Yeung, Ph.D., C. Anthony Blau, MD, Vivian G. Oehler, MD, Su-In Lee, Ph.D., Christopher P. Miller, PhD, Sylvia Chien, Timothy Martins, PhD, Elihu H. Estey, MD, Pamela S. Becker, MD, PhD

Blood (2013) 122 (21): 483.

https://doi.org/10.1182/blood.V122.21.483.483

Published: 2013

Journal Articles

Epo-Independent Proliferation and Differentiation of Genetically Modified Erythroid Progenitor Cells Using a Chemical Inducer of Dimerization.

Chris P. Miller, PhD, Songmao Zheng, C. Anthony Blau, MD

Blood (2006) 108 (11): 1159.

https://doi.org/10.1182/blood.V108.11.1159.1159

Published: 2006

Journal Articles

NIH-Funded Research Using Human Embryonic Stem Cells.

C. Anthony Blau, MD, Angelique Nelson, BS, Carol B. Ware, PhD

Blood (2005) 106 (11): 4232.

https://doi.org/10.1182/blood.V106.11.4232.4232

Published: 2005

Journal Articles

Receptor Specificity in the Self-Renewal, Survival and Differentiation of Hematopoietic Stem and Progenitor Cells In Vitro and In Vivo.

Ingrid Lintmaer, MD, Michael A. Weinreich, BS, Linlin Wang, PhD, Denny Liggitt, PhD, Michael Harkey, PhD, C. Anthony Blau, MD

Blood (2005) 106 (11): 3163.

https://doi.org/10.1182/blood.V106.11.3163.3163

Published: 2005

Journal Articles

Expansion of Genetically Modified Primary Human Hematopoietic Cells Using a Cell Growth Switch.

Linlin Wang, MD, PhD, Brent Wood, MD, Greg Levin, C. Anthony Blau, MD

Blood (2005) 106 (11): 3044.

https://doi.org/10.1182/blood.V106.11.3044.3044

Published: 2005

Journal Articles

In Vivo Expansion of Transduced Human Erythroid Cells Using an Mpl-Based Cell Growth Switch.

Yasuo Nagasawa, PhD, Brent Wood, MD, Cynthia L. Nourigat, Thalia Papayannopoulou, MD, C. Anthony Blau, MD

Blood (2004) 104 (11): 2100.

https://doi.org/10.1182/blood.V104.11.2100.2100

Published: 2004

Journal Articles

A Conditional Fibroblast Growth Factor Receptor-1 Derivative Stimulates Extensive Self Renewal of Genetically Modified Primary Hematopoietic Cells.

Ingrid Lintmaer, MD, Michael A. Weinreich, C. Anthony Blau, MD

Blood (2004) 104 (11): 493.

https://doi.org/10.1182/blood.V104.11.493.493

Published: 2004

NARROW

Variation in the Treatment of Multiple Myeloma in the Real World

A Precision Medicine Approach Incorporating Both Molecular and In Vitro Functional Data to Treat Patients with Relapsed/Refractory Acute Myeloid Leukemia

Toward Individualized Therapy: Correlation of Mutation Analysis with in Vitro high Throughput Drug Sensitivity Testing in New Diagnosis and Relapsed Acute Myeloid Leukemia

Feasibility Trial of Individualized Therapy for Relapsed or Refractory Acute Myeloid Leukemia Based on a High Throughput in Vitro Drug Sensitivity Assay

Big Data Approach to Identify Molecular Basis for Drug Sensitivity Phenotypes in Acute Myeloid Leukemia

Characterization Of FLT3 /ITD Resistant Cells and Identification Of Novel Therapeutic Targets Utilizing High Throughput Drug Screening

Proof-Of-Concept Study For Precision Medicine With Chromosome Genomic Array Testing (CGAT) For Drug Sensitivity Screening In Acute Myeloid Leukemia

Personalized Approach To Treatment of Acute Myeloid Leukemia Using a High-Throughput Chemosensitivity Assay

Epo-Independent Proliferation and Differentiation of Genetically Modified Erythroid Progenitor Cells Using a Chemical Inducer of Dimerization.

NIH-Funded Research Using Human Embryonic Stem Cells.

Receptor Specificity in the Self-Renewal, Survival and Differentiation of Hematopoietic Stem and Progenitor Cells In Vitro and In Vivo.

Expansion of Genetically Modified Primary Human Hematopoietic Cells Using a Cell Growth Switch.

In Vivo Expansion of Transduced Human Erythroid Cells Using an Mpl-Based Cell Growth Switch.

A Conditional Fibroblast Growth Factor Receptor-1 Derivative Stimulates Extensive Self Renewal of Genetically Modified Primary Hematopoietic Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only